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Several studies have already demonstrated that the incomplete polymerization of resin-based dental materials causes the release
of monomers which might affect cell metabolism. The aim of this study was to investigate the effects of triethylene glycol
dimethacrylate, 1,4-butanediol dimethacrylate, urethane dimethacrylate, and 2-hydroxyethyl methacrylate on (1) cellular energy
metabolism, evaluating oxygen consumption rate, glucose consumption, glucose 6-phosphate dehydrogenase activity, and lactate
production, and (2) cellular redox status, through the evaluation of glutathione concentration and of the activities of enzymes
regulating glutathione metabolism. Methods. Human pulp cells were used and oxygen consumption was measured by means
of a Clark electrode. Moreover, reactive oxygen species production was quantified. Enzymatic activity and glucose and lactate
concentrations were determined through a specific kit. Results. Triethylene glycol dimethacrylate, 1,4-butanediol dimethacrylate,
and 2-hydroxyethyl methacrylate induced a decrease in oxygen consumption rate, an enhancement of glucose consumption, and
lactate production, whilst glucose 6-phosphate dehydrogenase and glutathione reductase activity were not significantly modified.
Moreover, the monomers induced an increase of reactive oxygen species production with a consequent increase of superoxide
dismutase and catalase enzymatic activities. A depletion of both reduced and total glutathione was also observed. Conclusion. The
obtained results indicate that dental monomers might alter energy metabolism and glutathione redox balance in human pulp cells.
1. Introduction
Resin-based materials utilized in medicine largely in den-
tistry and also in orthopaedics [1, 2] are complex mixed
materials consisting of an organic polymerizable matrix and
an inorganic reinforcing filler coupled through a silanic agent
[3, 4]. Resinous matrix is frequently composed of bisphenol
A glycerolate dimethacrylate (Bis-GMA) with the addition
of other methacrylic monomers whose main function is to
improve the handling and get an easier incorporation of the
filler. The most used compounds, because of their low vis-
cosity, are triethylene glycol dimethacrylate (TEGDMA), 2-
hydroxyethyl methacrylate (HEMA), urethane dimethacry-
late (UDMA), and, occasionally, 1,4-butanediol dimethacry-
late (BDDMA).
After performing dental restorations with the above
described materials, small amounts of uncured monomers
are released [5] into the oral cavity and—through dentinal
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diffusion [6–8]—in pulpal tissues, where monomers like
HEMA and TEGDMA may reach millimolar concentra-
tions [9], high enough to cause detrimental effects such as
alteration of the cellular redox balance and other adverse
biological effects [10]. Several researchers established that
various dental monomers are able to cause potential damages
to the oral soft tissues in vivo [11] and remarkable cyto-
toxicity effects in vitro [6–12]. In particular, the in vitro
studies on TEGDMA, Bis-GMA, and HEMA showed that
such monomers have genotoxic, allergenic [13], cytotoxic,
estrogenic (mainly in the case of Bis-GMA and TEGDMA),
and mutagenic activity and that they alter lipid metabolism,
glutathione (GSH) concentration, reactive oxygen species
(ROS) production, cell cycle, energy metabolism, and mito-
chondrial activity [14–22]. Moreover, TEGDMA suppresses
heat shock protein 72 expression in human monocytes [23]
and regulates glutathione transferase P1 activity [24], while
HEMA reduces intracellular tyrosine phosphorylation [25].
UDMA induces cell cycle perturbation, ROS overproduction
and GSH depletion in CHO-K1 cells [26].
Oxygen consumption rate is reputed to be a good marker
of mitochondrial functionality: in fact the decrease of oxygen
consumption capability causes the reduction of ATP produc-
tion so that the cells have to boost anaerobic glycolysis to get
ATP from sugars thus increasing glucose consumption and
lactate production [20].
It has been reported that about 0.1–0.5% of molecu-
lar oxygen consumed during mitochondrial respiration is
converted to ROS: some electrons can in fact, escape from
the mitochondrial electron-transfer chain and react with O
2
to form superoxide anion (O
2
∙−) [27–29] which, in turn,
can be reduced to hydroxyl radical (OH∙−) and hydrogen
peroxide (H
2
O
2
) through superoxide dismutase (SOD) cat-
alytic activity [30]. H
2
O
2
was further transformed into O
2
and H
2
O by the activity of other enzymes like catalase and
glutathione peroxidase [31]. When the levels of hydrogen
peroxide are too low to activate catalase, the dismutation
of such chemical species is carried out by the activation
of glutathione peroxidase, an enzyme that needs GSH to
perform its catalytic activity [31]. Enzymatic (i.e., dismutases,
catalases and peroxidases) or nonenzymatic (i.e., vitamins A,
C, and E and GSH) defensive systems are adopted by the cells
against ROS because an increase of these chemical species
inside the cells can induce oxidative alterations of biological
macromolecules like proteins, lipids, and DNA with possible
loss of their functions [32].
The present work was therefore carried out to evaluate
the effects of subcytotoxic concentrations (i.e., values able
to induce a mortality not higher than 20% in respect to
control) of HEMA, TEGDMA, UDMA, and BDDMA on
human dental pulp cells (HPCs). At first, possible alterations
of cellular energy metabolism were considered evaluating
oxygen consumption rate, glucose disposal, and lactate pro-
duction. Subsequently, cellular redox status was examined
determining ROS production, GSH concentration, and the
activity of glucose 6-phosphate dehydrogenase (G6PDH),
glutathione reductase (GR), superoxide dismutase (SOD),
and catalase.
2. Materials and Methods
All chemicals and reagents were obtained from Sigma-
Aldrich Srl, Milan, Italy, unless otherwise indicated.
2.1. Cell Culture. HPCs from healthy patient (obtained with
informed consent and with approval from the Ethics Com-
mittee of the Catholic University) were used in this study.
Culture was performed as previously described [33]. The
tooth pulp tissue was cut into small pieces and incubated
in phosphate buffered saline (PBS), containing type I col-
lagenase (3mg/mL) and dispase (4mg/mL), for 60min at
37∘C. The cells were plated in tissue culture flasks (25 cm2)
with Dulbecco’s modified Eagles’ medium (DMEM), sup-
plemented with 10% fetal calf serum (FCS), L-glutamine
(2mmol/L), streptomycin (100.0𝜇g/mL), and penicillin
(1000 units/mL) at 37∘C in humidified atmosphere (95% air,
5% CO
2
). The medium was replaced before the formation
of cell monolayer. Cells at subconfluence, obtained with no
more than 5 passages, were used in all experiments.
2.2. Preparation of Methacrylates Solutions. Stock dimethyl
sulfoxide (DMSO) solutions of TEGDMA (from 0.2mol/L
to 3.0mol/L), UDMA (from 0.05mol/L to 0.2mol/L), and
BDDMA (from 0.1mol/L to 0.4mol/L) were prepared imme-
diately before use. A final concentration of DMSO (0.1% v/v)
was utilized in all samples because—as shown by preliminary
studies—it did not induce any alterations in the parameters
under study.
DMEM containing the monomers was then added to
the exponentially growing HPCs at the following final con-
centrations: TEGDMA (3.0, 1.5, 0.7, 0.4, and 0.2mmol/L),
UDMA (0.2, 0.1, and 0.05mmol/L) and BDDMA (0.4, 0.2,
and 0.1mmol/L).
DMSO was absent only in cells treated with HEMA
because this monomer is hydrophilic and—therefore—it can
be added purely to the medium to reach a final concentration
ranging from 1.0mmol/L to 8.0mmol/L.
2.3. Cell Viability. Cytotoxic concentrations of TEGDMA,
HEMA, UDMA, and BDDMA monomers were determined
by theMTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide) assay [34]. HPCs were seeded in a 96-well
tissue culture dish at 8000 cells/well and, after 24 h of incu-
bation, the mediumwas removed and the cell monolayer was
incubated with the above indicated monomer concentrations
for 24 h. The medium was replaced by a solution of MTT
(0.5mg/mL, 100𝜇L/well) in PBS, and the cells were incubated
at 37∘C for 1 h in a 5% CO
2
atmosphere. The MTT solution
was replaced withDMSO (100 𝜇L/well) and gently swirled for
10min. The optical density was measured by a plate reader
at 540 nm (Packard Spectracount, Packard BioScience, Meri-
den, CT, USA).The results were expressed as the percentages
of untreated cultures. Each experiment was performed five
times in quadruplicate.
On the basis of the obtained results the highest concen-
tration of each monomer inducing a decrease of succinate
dehydrogenase (SDH) activity—less than 20% compared to
control—was selected [35]. In order to confirm the obtained
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results and to evaluate cell number, the HPCs were treated
as described above and the number of viable cells was
determined by trypan blue exclusion test [36]. In this way
the subcytotoxic concentration for each monomer was deter-
mined and used in all the following experiments.
2.4. Assays Condition. Exponentially growing HPCs (1.0 ×
106) inDMEM(20.0mL)were incubatedwith eachmonomer
for 4 and 24 h. On the basis of cellular toxicity results,
all the experiments described below were performed with
HEMA (4.0mmol/L), or TEGDMA (0.7mmol/L), or UDMA
(0.2mmol/L), or BDDMA (0.4mmol/L), or DMSO 0.1%, or
culture medium (control) and the incubations were per-
formed in a humidified atmosphere of 5% CO
2
.
2.4.1. Metabolic Assays
(a) Oxygen Consumption Rate. HPCs were incubated with the
monomers, washed with PBS solutionwithout Ca++ orMg++,
counted by trypan blue exclusion test, resuspended in Krebs
Ringer Phosphate (KRP) buffer (1.0× 106 cells/mL) andfinally
utilized to monitor the oxygen consumption rate under
constant stirring, for 10 min at room temperature (Oxygen
Meter Model 781, Strathkelvin Instruments, Glasgow, UK).
Results are expressed as percentage of oxygen consumption
rate of treated cells versus control.
(b) Determination of Cellular Glucose Consumption. HPCs
were incubated with the monomers; then the cellular protein
content was determined through BioRad ProteinAssay, using
bovine serum albumin as standard.
Cellular glucose consumption was measured in the cul-
ture supernatants with the appropriate reagent kit (glucose
GOD-PAP,RocheDiagnostics). In order to normalize glucose
consumption at different cell numbers, datawere expressed as
the ratio
Glucose concentration (mg/dL)
Cellular proteins (mg)
. (1)
(c) Determination of Cellular Lactate Production. After the
incubation with monomers, the lactate concentration was
then determined in cell extracts: cellular pellets obtained
after centrifugation (400 g, 5min, 4∘C) were washed in PBS
solution and stored (−80∘C). Cell lysates were centrifuged
(20,000 g, 15min, 4∘C) and the collected supernatants were
used to determine the protein content as already indicated.
Lactate concentration was determined with the appro-
priate reagent kit (Lactate, Roche Diagnostics). In order to
normalize lactate production at different cell numbers, data
(expressed as percent of control) were calculated as the ratio
Lactate concentration (mg/dL)
Cellular proteins (mg)
. (2)
2.4.2. Cellular Redox Status Assays
(a) Glucose-6-Phosphate Dehydrogenase Activity. HPCs were
incubated with monomers; then the enzymatic activity was
determined in cell extracts (as already indicated). G6PDH
activity (measured as nmol/min/mg protein) was determined
bymeans of the absorbance increase induced by the reduction
of NADP+ to NADPH, at 340 nm [37].
(b) ROS Production. ROS production was measured using an
apolar oxidation-sensitive fluorescent probe 2󸀠,7󸀠-dichlorodi-
hydrofluorescein diacetate (H
2
DCF-DA). The latter readily
diffuses into the cells, where it is enzymatically deacetylated
by intracellular esterases to a polar nonfluorescent derivative
trapped inside. In the presence of ROS, the probe is oxidized
to 2󸀠,7󸀠-dichlorodihydrofluorescein (DCF); fluorescence lev-
els depend on the intracellular ROS concentration. The cells
were seeded in a 96-well microplate (5 × 103 cells/well) for
24 hrs. The H
2
DCF-DA probe (10mmol/L) was added for
20min at 37∘C in the dark. The cells were then washed with
PBS and monomers were added (cells with DMEM were
used as control). The H
2
DCF-DA probe was then added to
all samples and the formation of DCF was at once fluori-
metrically monitored using a Glomax Multidetection System
fluorometer (Promega, Milan, Italy) at 490 nm excitation and
526 nm emission wavelengths, for 4 h [38].
The viable cells in the microplate wells were estimated
using the MTT assay after each measurement. The amount
of viable cells present in each well was unchanged after 6 h
of incubation, both in presence and in absence (control) of
monomers. Because H
2
DCF-DA can react directly with the
hydroxyl radical but not with superoxide or H
2
O
2
, the ROS
detected in the resin monomer-treated cells were probably
hydroxyl radicals [39, 40].
(c) Cellular Glutathione Determination. After the incubation
with monomers, HPCs were washed twice with PBS, resus-
pended in trichloroacetic acid (6%, 100.0 𝜇L), and imme-
diately stirred. The lysed cells were centrifuged (20,000 g,
4min) and the supernatants were used to establish GSH and
GSH +GSSG (total glutathione) amount. GSH concentration
was determined by Ellman method [41] and modified by
Wataha et al. [42]: briefly the supernatant (40.0 𝜇L) was
added to Na
2
HPO
4
(0.30mol/L, 80 𝜇L) and 5,5󸀠-dithiobis[2-
nitrobenzoic acid] (DTNB, 0.04% in 1% sodium citrate,
10.0 𝜇L). Absorbance was measured at 405 nm (Packard
Spectracount, Packard BioScience Company, Meriden CT
USA) reporting the results as the percentage of treated versus
untreated cells. Total glutathione was estimated as follows:
a freshly prepared NaBH
4
aqueous solution (20.00mg/mL,
40.0 𝜇L) was added to the supernatant (40.0 𝜇L) previ-
ously shaken with ethyl ether (120.0 𝜇L) to remove the
lipophilic substances. After incubation of the mixture
(40min, 37∘C), HCl (1 N, 37.5𝜇L), acetone (40.0 𝜇L) and Tris
buffer (1.0mol/L, pH 8.5, 30.0 𝜇L) were added and an aliquot
of the solution (150.0𝜇L) was mixed with DTNB (0.04% in
1.0% sodium citrate, 10.0 𝜇L) to determine its concentration
spectrophotometrically, as described above.
(d) Glutathione Reductase Enzymatic Activity. HPCs were
incubated with the monomers. The enzymatic activity was
then determined in cell extracts obtained as already indi-
cated.The GR activity was determined according to Carlberg
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andMannervik [43], briefly: GR reduces GSSG to GSH at the
expenses of NADPH, whose disappearance can be checked
at 340 nm. Enzyme activity was expressed as nmol/min/mg
protein.
(e) SOD Enzymatic Activity. HPCs were incubated with one
of the monomers and SOD enzymatic activity was then
determined in cell extracts (obtained as already indicated);
the cellular pellets obtained after centrifugation (400 g, 5min,
4∘C) were washed with PBS solution and stored at −80∘C.
The enzymatic activity was measured (Packard Spectra-
count, Packard BioScience) using the appropriate SOD deter-
mination kit (19160 Fluka Analytical, Sigma-Aldrich, Milan,
Italy). Enzymatic activity was measured as nmol/min/mg
protein and expressed as percentage of the control group.
(f) Catalase Enzymatic Activity. After the incubation with
monomers, the HPCs intracellular extracts (obtained as
already indicated) were used to determine catalase activity by
means of a Packard Spectracount (Packard BioScience) using
the appropriate Catalase Assay kit (Sigma-Aldrich, Milan,
Italy). Enzymatic activity was measured as nmol/min/mg
protein and expressed as percentage of the control group.
2.5. Statistical Analysis. Data are expressed as the mean ±
standard deviations (SD) of at least 5 different experiments
performed in duplicate (𝑛 = 5). Statistical analysis was
performed by ANOVA with Bonferroni’s posttest, or Student
𝑡-test. A level of 𝑃 < 0.05 was assumed significant.
3. Results
3.1. Cell Viability. As expected, all tested monomers caused
a dose dependent decrease of cell vitality observed by
MTT (Figure 1(a)); thus, subcytotoxic concentrations for
each monomer were obtained. Results were confirmed using
trypan blue exclusion test (Figure 1(b)).
Each monomer was then used at the following
subcytotoxic concentrations: TEGDMA (0.7mmol/L),
HEMA (4.0mmol/L), UDMA (0.2mmol/L), and BDDMA
(0.4mmol/L).
3.2. Effects of HEMA, TEGDMA, UDMA and BDDMA on
Examined Parameters. Mitochondrial function was moni-
tored by determining respiration in HPCs suspensions.
HEMA, TEGDMA, and BDDMA caused a significant
decrease of cellular oxygen consumption rate versus cells
treated with DMSO (Figure 2). In particular, after 4 h of
incubation, the reduction is about 50%, whereas after 24 h O
2
consumption was decreased to approximately 20% of DMSO
treated cells (Figure 2).
As a consequence of this alteration, the glucose consump-
tion (Figure 3) and the lactate production (just after 24 h)
(Figure 4) significantly increased, whilst G6PDH and GR
activity (Figures 5 and 6) were not significantlymodifiedwith
respect to control cells.
To determine the role of ROS production in monomers
toxicity, H
2
DCF-DA cellular oxidation was monitored. After
4 h of incubation, monomers caused an increase of ROS pro-
duction (about 30–40%) in comparison with DMSO-treated
cells (Figure 7). An increase of SOD (albeit slight) and cata-
lase enzymatic activity, after 24 h, was consequently observed
(Figures 8 and 9, resp.).
Moreover, TEGDMA, HEMA, and BDDMA induced a
significant depletion of intracellular GSH after 4 h of incuba-
tion (about 30% of DMSO-treated cells) (Figures 10(a) and
10(b), left panel); such phenomenon completely disappears
after 24 h incubation (Figures 10(a) and 10(b), right panel).
Interestingly, no increase of intracellular GSSG occurred
during this period. UDMA did not induce any alterations of
examined parameters (Figures 2–10).
4. Discussion
Dental composite resins have been employedworldwide since
the mid 1950s for adult and young patients: a careful eval-
uation of the interactions between the components of these
materials and the host is thereforemandatory. In vitro tests are
especially suitable for this purpose, allowing the independent
assessment of the contributions of each resin component
and the different metabolic aspects, whereas the same was
not obtainable with in vivo trials [44]. Over the years, the
biocompatibility concept evolved, taking into account not
only the possible cytotoxic effects but also their underlying
biochemical causes.
HPCs used in this study may get into direct contact with
methacrylicmonomers at concentrations capable of inducing
alterations in several metabolic parameters. It is known that
HEMA, TEGDMA, UDMA, and BDDMA can impair both
energetic and redox metabolism in HL-60 cells [20, 21] and
it was therefore of great interest to investigate the effect of
these compounds also on HPCs which represent one of their
potential cellular targets, especially in consideration of the
multiple functions expleted by these cells, principally dentin
formation and nutrition of the mineralized tissues.
For each monomer, subcytotoxic concentrations (i.e.,
values able to induce a decrease of vitality less than 20% of
control) were selected by trypan blue and MTT cytotoxicity
test to evaluate energy metabolism and redox status of the
treated cells.
The experiments on the alterations of the energy meta-
bolism were carried out by analyzing the cellular respiration
rate, an index of mitochondrial functionality, by measuring
the oxygen uptake and by monitoring the glucose consump-
tion, which are all strictly connected parameters [45].
In this study, ROS production was analyzed using
H
2
DCF-DA, a fluorescent probe readily oxidized by ROS.
Superoxide dismutase and catalase were tested because
the activity of the former enzyme increases during oxidative
stress, catalyzing the breakdown of superoxide radicals (thus
providing the first line of defense against oxygen toxicity)
[46], whereas the latter catalyzes the transformation of
hydrogen peroxide into oxygen and water [47].
GSH redox metabolism was investigated, evaluating GR
and G6PDH activity: the former enzyme is in fact NADPH
dependent and catalyzes GSSG reduction whereas the latter
regulates the rate of the hexosemonophosphate (HMP) shunt
BioMed Research International 5
Determination of sublethal monomer concentrations
by MTT assay
0
50
100
150
TEGDMA HEMA UDMA BDDMA
%
 v
er
su
s c
on
tro
l
D
M
SO
0
.1
%
3
.0
m
M
1
.5
m
M
0
.7
m
M
0
.4
m
M
0
.2
m
M
8
.0
m
M
4
.0
m
M
2
.0
m
M
1
.0
m
M
0
.2
m
M
0
.1
m
M
0
.0
5
m
M
0
.4
m
M
0
.2
m
M
0
.1
m
M
(a)
Determination of sublethal monomer concentrations
by trypan blue assay
0
50000
100000
150000
200000 TEGDMA HEMA UDMA BDDMA
ce
lls
/m
L
C
on
tro
l
3
.0
m
M
1
.5
m
M
0
.7
m
M
0
.4
m
M
0
.2
m
M
8
.0
m
M
4
.0
m
M
2
.0
m
M
1
.0
m
M
0
.2
m
M
0
.1
m
M
0
.0
5
m
M
0
.4
m
M
0
.2
m
M
0
.1
m
M
D
M
SO
0
.1
%
(b)
Figure 1: Evaluation of subcytotoxic concentrations. HPCs were treated with different concentrations of monomers for 24 h. The viability
was determined byMTT assay (a) and the number of viable cells was evaluated by trypan blue exclusion test (b). On the basis of the obtained
results, the highest concentration of eachmonomer inducing a decrease of cell numbers less than 20%was selected.MTT results were reported
as percentage of viable cells versus control ± SD. Trypan blue data were reported as cell number in 1mL of DMEM. Data are the mean of 5
different experiments performed in quadruplicates (𝑛 = 5).
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Figure 2: Oxygen consumption rate after cell treatment with HEMA (4.0mmol/L), TEGDMA (0.7mmol/L), BDDMA (0.4mmol/L), or
UDMA (0.2mmol/L). The results were reported as percentage of oxygen consumption rate of treated cells versus control ± SD; ∗(𝑃 < 0.05)
and ∗∗(𝑃 < 0.01) significantly different fromDMSO treated cells. Data are themean of 5 different experiments performed in duplicate (𝑛 = 5).
[48], that is, the metabolic pathway producing NADPH [49]
from glucose.
Glucose disposal was also evaluated by determining lac-
tate production and G6PDH enzymatic activity. The increase
of lactate production indicates that glucose is disposed of
through anaerobic glycolysis to produce energy, whereas the
increase of G6PDH activity suggests that the sugar is utilized
to generate NADPH—in the hexose monophosphate shunt
(HMP)—for the reduction of GSSG by GR catalysis [50, 51].
The obtained results showed that BDDMA, HEMA, and
TEGDMA induced a decrease of oxygen consumption rate, a
phenomenon probably due to an impairment of mitochon-
dria and an increase of glucose consumption which involves,
through anaerobic glycolysis, a consequent increase of ATP
production in the cells. To confirm that glucose was con-
sumed by glycolysis and not by HMP shunt, lactate produc-
tion and G6PDH activity were evaluated. The experimental
results showed that the three monomers induced an increase
of cellular lactate production without alteration of G6PDH
activity and that, consequently, glucose was disposed of
mainly through anaerobic glycolysis to produce energy.
As expected, BDDMA,HEMA, andTEGDMA induced—
even at subcytotoxic concentration—a decrease of total GSH
(i.e., GSH + GSSG), which probably depends on the direct
binding of the tripeptide to the monomers rather than to its
oxidation, as already observed in previous papers [52–57]. In
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Figure 3: Glucose concentration in DMEM of HPCs untreated
and treated with HEMA (4.0mmol/L), TEGDMA (0.7mmol/L),
BDDMA (0.4mmol/L), or UDMA (0.2mmol/L); ∗(𝑃 < 0.05) and
∗∗(𝑃 < 0.01) significantly different from control. Data are expressed
as the mean ± SD of 5 different experiments performed in duplicate
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Figure 4: Lactate production by HPCs cells untreated and treated
with HEMA (4.0mmol/L), TEGDMA (0.7mmol/L), BDDMA
(0.4mmol/L), or UDMA (0.2mmol/L). The results were reported
as percentages of lactate produced by treated cells versus control ±
(SD); ∗(𝑃 < 0.05) significantly different from DMSO treated cells.
Data are themean of 5 different experiments performed in duplicate
(𝑛 = 5).
fact, the thiol group of GSH can bind, via a Michael addition
reaction [58], the 𝛼,𝛽-unsaturated carbon-carbon moiety of
methacrylates causing the detoxification of these xenobiotics
[24, 59].The reaction is catalyzed by glutathione S-transferase
(GST), one of several enzyme forms belonging to amultigene
family involved in detoxification processes [60–62].
Data regarding the enzymatic activity of GR and G6PDH
further confirm the above considerations: in fact, the activity
of both enzymes is unaffected by monomers because the
GSSG concentration is unchanged.
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Figure 5: G6PDH activity of HPCs untreated and treated with
HEMA (4.0mmol/L), TEGDMA (0.7mmol/L), BDDMA
(0.4mmol/L), or UDMA (0.2mmol/L). Data are expressed as
the mean ± SD of 5 different experiments performed in duplicate
(𝑛 = 5).
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Figure 6: GR activity of HPCs untreated and treated with HEMA
(4.0mmol/L), TEGDMA (0.7mmol/L), BDDMA (0.4mmol/L), or
UDMA (0.2mmol/L). Data are expressed as the mean ± SD of 5
different experiments performed in duplicate (𝑛 = 5).
As already reported in literature [17–21], BDDMA,
TEGDMA and HEMA provoked an overproduction of ROS
and it is interesting to note that the observed decrease of oxy-
gen consumption rate may provide an important indication
about the source of radicals. As a matter of fact, the mito-
chondrial respiratory chain is a major site of ROS production
inside cell and, when the rate of electron flow (coupled
with oxygen consumption) is slow, electrons accumulated
in the respiratory chain increase the reduction state of the
electron transport chain components and, consequently, ROS
formation [30].
A 24 h cell incubation with HEMA, TEGDMA, and
BDDMA caused, in the reported experimental conditions,
an increase of the enzymatic activity of SOD (albeit slightly)
and catalase, subsequent to the increased ROS production
(observed after 4 h).
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Figure 7: ROS produced by HPCs untreated and treated with
HEMA (4.0mmol/L), TEGDMA (0.7mmol/L), BDDMA
(0.4mmol/L) orUDMA(0.2mmol/L). ∗(𝑃 < 0.05) and ∗∗(𝑃 < 0.01)
significantly different fromcontrol. Data are expressed as themean±
SD of 6 different experiments performed in quintuplicate (𝑛 = 6).
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Figure 8: SOD activity of HPCs untreated and treated with HEMA
(4.0mmol/L), TEGDMA (0.7mmol/L), BDDMA (0.4mmol/L), or
UDMA (0.2mmol/L). The results were reported as percentage of
enzymatic activity by treated cells versus control ± SD; ∗(𝑃 < 0.05)
and ∗∗(𝑃 < 0.01) significantly different from DMSO treated cells.
Data are the mean of 5 different experiments performed in triplicate
(𝑛 = 5).
In the reported experimental conditions UDMA did not
cause alterations of the examined parameters, probably
because its concentration was too low.
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Figure 9: Catalase activity of HPCs untreated and treated
with HEMA (4.0mmol/L), TEGDMA (0.7mmol/L), BDDMA
(0.4mmol/L), or UDMA (0.2mmol/L). The results were reported
as percentage of enzymatic activity of treated cells versus control ±
SD; ∗(𝑃 < 0.05) and ∗∗(𝑃 < 0.01) significantly different fromDMSO
treated cells. Data are themean of 5 different experiments performed
in triplicate (𝑛 = 5).
5. Conclusion
All the above-described results seem, therefore, to draw the
following overview: TEGDMA, HEMA, and BDDMA alter
mitochondrial function triggering two types of correlated
events.
(1) Increase of glucose consumption through glycolysis
to produce ATP. In fact, enzymes involved in the
hexose monophosphate shunt do not increase their
activity while lactate production is increased.
(2) Increase of ROS production (hydroxyl radicals that
are derived from superoxide and peroxide) which
determines the activation of SOD and catalase in
order to protect the cells. The catalase activation
was also caused by GSH lack and by the consequent
impossibility of glutathione peroxidase to catalyze
the tripeptide oxidation to counteract the increase
of peroxide. On the other hand, an activation of
glutathione peroxidase should have led to an increase
of GR and G6PDH activity not actually observed.
The present study thus clearly demonstrates that, also
at subcytotoxic concentration, HEMA, TEGDMA, and
BDDMAmight affect the mitochondrial activity by inducing
alterations in energy metabolism, oxidative stress, and GSH
balance in HPCs.
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Figure 10: Concentration of reduced and total glutathione in HPCs untreated and treated with HEMA (4.0mmol/L), TEGDMA
(0.7mmol/L), BDDMA (0.4mmol/L), or UDMA (0.2mmol/L). Results are expressed as percentage of treated cells versus control ± SD;
∗(𝑃 < 0.05) and ∗∗(𝑃 < 0.01) significantly different from DMSO treated cells. Data are the mean of 5 different experiments performed in
duplicate (𝑛 = 5).
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